Congratulations to @RiyaPatel_1 for an outstanding completion seminar! Complete with great science, moving acknowledgments and very proud supervisors indeed π The lab is super excited for the next chapter in your academic career π
π Heartiest congratulations to Dr. @MichaelKuanChi1 on your successful PhD completion seminar! Your hard work has paid off, and we're so proud of you! Can't wait to see your future accomplishments! Here's to many more successes ahead! π₯ @PMacStudents
The team is stoked for @MichaelKuanChi1 who has received the Paul Dear Postdoctoral Fellowship! We cannot wait to see you go on to make headway in the space of pancreatic cancer treatment using RNA biology. #Pancare#DareToHope
Daring to hope for a pancreatic cancer advance, @MichaelKuanChi1 will today be announced as recipient of the Paul Dear Postdoctoral Fellowship - at the #aflhawkscats "Dare to Hope" match. Legacy of the late Hawthorn great Paul Dear. More: https://t.co/ZGlSJiIWoO
Sending a massive shout-out to the incredible @Smith_Lorey for kicking some serious career goals. What a way to wrap up the year on an absolute high! Way to go, Lorey β you're a true inspiration! π #WomenInSTEM@PMPostdocs@PeterMacRes π
Major Milestone Unlocked! π Dr. Reem Saleh, our phenomenal postdoc, just secured her FIRST grant! π Congratulations to Dr. Reem Saleh and all the incredible recipients making waves in research! π! @PMPostdocs@PeterMacCC
Thrilled to share that @tourdecure_aus released the outcomes of theirΒ 2023 Grant RoundΒ and Peter Mac achieved a remarkable 100 percent success rate on full applications, with 10 projects funded worth more than $800K.
Read more: https://t.co/QpmarvgAHM
#MayIsMelanomaAwarenessMonth. Dr Aparna Rao, a postdoc with @McArthurLab, investigates the metabolism of melanoma cells. Her research may better predict patient relapse and help us to understand what causes resistance to immunotherapy and other targeted therapies.
We're in Philly for all things melanoma!! #SMRCongress Be sure to swing by @RiyaPatel_1 's posters (no. 197 & 198) to see some exciting unpublished data on cross-resistance between immunotherapy and targeted therapy. @Smith_Lorey@SocietyMelanoma
Ending the week with Veronica's outstanding confirmation seminar!! Supervisors could not be more proud of her achieving this very important milestone of her PhD π₯³π₯ @PMacStudents#phdlife
@Prof_G_McArthur Launching the highly anticipated #VCCCA23 conference with great enthusiasm! We're currently immersed in the captivating presentations from an impressive lineup of speakers, all centered around the exciting theme of "Exploring Beyond Breakthroughs!"ππ¬
The United States @DeptofDefense has called on Peter Mac to help in its fight against #melanoma, granting a million dollars to researcher Dr @Smith_Lorey.
Read the full story: https://t.co/4vAK33ag1S
Congratulations to three of @PeterMacCC's most promising clinical researchers Dr Aparna Rao, Dr Julia Dubowitz and Dr Lewis Au, who have received 2023 Discovery Partner Fellowships!
Read more: https://t.co/Brk0j8QFXf
Interested in targeted therapy resistance in cancer? Check out our recent perspective piece on whether targeted therapy resistance in cancer is inevitable. Spoiler, we donβt think it is.
Is resistance to targeted therapy in cancer inevitable? Check out our perspective on a landmark study from @lab_marine that elegantly shows genetic vs non-genetic resistance in melanoma are predictable events. https://t.co/HgCaceQflW
@McArthurLab at @PeterMacRes is seeking an enthusiastic postdoc to investigate the role the immune system plays in melanoma therapy response and resistance. Utilizing scRNA seq, CRISPR screens, and in vivo mouse models and more. See here for more info: https://t.co/lRccXacPg6
@McArthurLab at @PeterMacRes is seeking an enthusiastic postdoc to investigate the role the immune system plays in melanoma therapy response and resistance. Utilizing scRNA seq, CRISPR screens, and in vivo mouse models and more. See here for more info: https://t.co/lRccXacPg6